Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor immunity

被引：16
作者：
Kato, Shingo [1 ]
Berzofsky, Jay A. [2 ]
Terabe, Masaki [2 ]
机构：
[1] Yokohama City Univ, Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan
[2] NCI, Mol Immunogenet & Vaccine Res Sect, Vaccine Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
关键词：
natural killer T cell; type II natural killer T cell; tumor immunology; immune regulation; immunosuppression; immunotherapy; lipid antigens; transforming growth factor beta; GROWTH-FACTOR-BETA; INVARIANT NKT CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; INFLAMMATORY-LIVER-DISEASE; GAUCHER-DISEASE; CD1D EXPRESSION; ADIPOSE-TISSUE; ALPHA-GALACTOSYLCERAMIDE; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS;
D O I：
10.3389/fimmu.2018.00314
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Natural killer T (NKT) cells are a unique T cell subset that exhibits characteristics from both the innate immune cells and T cells. There are at least two subsets of NKT cells, type I and type II. These two subsets of NKT cells have opposite functions in antitumor immunity. Type I NKT cells usually enhance and type II NKT cells suppress antitumor immunity. In addition, these two subsets of NKT cells cross-regulate each other. In this review, we mainly focus on immunosuppressive NKT cells, type II NKT cells. After summarizing their definition, experimental tools to study them, and subsets of them, we will discuss possible therapeutic applications of type II NKT cell pathway targeted therapies.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion
    Dhodapkar, KM
    Cirignano, B
    Chamian, F
    Zagzag, D
    Miller, DC
    Finlay, JL
    Steinman, RM
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (06) : 893 - 899
  • [32] Radiation-induced matrix metalloproteinases limit natural killer cell-mediated anticancer immunity in NCI-H23 lung cancer cells
    Heo, Woong
    Lee, Young Shin
    Son, Cheol Hun
    Yang, Kwangmo
    Park, You Soo
    Bae, Jaeho
    MOLECULAR MEDICINE REPORTS, 2015, 11 (03) : 1800 - 1806
  • [33] Natural killer group 2D-major histocompatibility complex class I polypeptide-related sequence A activation enhances natural killer cell-mediated immunity against hepatocellular carcinoma: A review
    Arai, Jun
    Okumura, Akinori
    Kato, Naoya
    Ito, Kiyoaki
    HEPATOLOGY RESEARCH, 2024, 54 (05) : 420 - 428
  • [34] Tumor-specific CD8-positive T cell-mediated antitumor immunity is implicated in the antitumor effect of local hyperthermia
    Ando, Ken
    Suzuki, Yoshiyuki
    Kaminuma, Takuya
    Yoshimoto, Yuya
    Oike, Takahiro
    Okonogi, Noriyuki
    Sato, Hiro
    Tamaki, Tomoaki
    Noda, Shin-Ei
    Mimura, Kosaku
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 35 (01) : 226 - 231
  • [35] Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells
    Werlenius, Olle
    Aurelius, Johan
    Hallner, Alexander
    Akhiani, Ali A.
    Simpanen, Maria
    Martner, Anna
    Andersson, Per-Ola
    Hellstrand, Kristoffer
    Thoren, Fredrik B.
    ONCOTARGET, 2016, 7 (22) : 32046 - 32053
  • [36] Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes
    Lawson, J. M.
    Tremble, J.
    Dayan, C.
    Beyan, H.
    Leslie, R. D. G.
    Peakman, M.
    Tree, T. I. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 (03) : 353 - 359
  • [37] Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)
    Moreno, Maria
    Mol, Berber M.
    von Mensdorff-Pouilly, Silvia
    Verheijen, Rene H. M.
    von Blomberg, B. Mary E.
    van den Eertwegh, Alfons J. M.
    Scheper, Rik J.
    Bontkes, Hetty J.
    CANCER LETTERS, 2008, 272 (01) : 70 - 76
  • [38] Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
    Zhang, Lianjun
    Donda, Alena
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [39] Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency
    Sagami, Shintaro
    Ueno, Yoshitaka
    Tanaka, Shinji
    Fujita, Akira
    Niitsu, Hiroaki
    Hayashi, Ryohei
    Hyogo, Hideyuki
    Hinoi, Takao
    Kitadai, Yasuhiko
    Chayama, Kazuaki
    PLOS ONE, 2017, 12 (01):
  • [40] Low-frequency ultrasound-induced VEGF suppression and synergy with dendritic cell-mediated anti-tumor immunity in murine prostate cancer cells in vitro
    Zhang, Wei
    Shou, Wen-De
    Xu, Yan-Jun
    Bai, Wen-Kun
    Hu, Bing
    SCIENTIFIC REPORTS, 2017, 7
12345